Paper · 29922827
Cited by335
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 463 citations.
1 to 20 of 335
Download this page as JSON| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,935,641 | Global and registry-based patterns of pancreatic cancer: GLOBOCAN 2020, CI5plus trends (2000-2017), and demographic projections to 2040. | Front Oncol | 2026 | https://conductscience.org/library/papers/42935641 | PubMed |
| 42,689,189 | A Heterogeneous Phenotypic Presentation of a PALB2 Mutation Carrier With Multiple Metachronous Primary Malignancies: A Case Report. | Cureus | 2026 | https://conductscience.org/library/papers/42689189 | PubMed |
| 42,654,051 | Emerging Precision Therapeutic Strategies in Pancreatic Ductal Adenocarcinoma: KRAS Targeting, DDR Vulnerabilities, Immune Redirection, and Tumor Microenvironment Remodeling. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42654051 | PubMed |
| 42,557,274 | Progress, challenges, and future directions of pancreatic cancer surveillance in high-risk populations. | Commun Med (Lond) | 2026 | https://conductscience.org/library/papers/42557274 | PubMed |
| 42,511,746 | Hereditary Pancreatic Cancer: Genetic Risk, Surveillance Strategies, and Therapeutic Implications. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511746 | PubMed |
| 42,507,335 | SEOM‑GETTHI clinical guideline for the practical management of molecular platforms (update 2026). | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/42507335 | PubMed |
| 42,498,744 | Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025). | Br J Cancer | 2026 | https://conductscience.org/library/papers/42498744 | PubMed |
| 42,487,270 | Genomic Alterations and Their Clinical Implications in Pancreatic Ductal Adenocarcinoma in a Large-Scale Chinese Cohort. | Cancer Med | 2026 | https://conductscience.org/library/papers/42487270 | PubMed |
| 42,440,005 | Focal Pancreatic Parenchymal Atrophy and Delayed Enhancement in Early Pancreatic Ductal Adenocarcinoma: A Narrative Review of Pathologic Basis, Diagnostic Pitfalls, and Evidence Limitations. | Dig Dis Sci | 2026 | https://conductscience.org/library/papers/42440005 | PubMed |
| 42,376,674 | DNA damage response inhibitors in pancreatic cancer: progress and challenges. | Front Oncol | 2026 | https://conductscience.org/library/papers/42376674 | PubMed |
| 42,372,208 | Implementing Timely Germline Genetic Testing for Patients With Pancreatic Cancer Using a Genetics Copilot for Point-of-Care Education and Health Assessment. | JCO Precis Oncol | 2026 | https://conductscience.org/library/papers/42372208 | PubMed |
| 42,277,390 | An integrative mutational and network analysis of pancreatic cancer reveals key genes, and signalling pathways. | Funct Integr Genomics | 2026 | https://conductscience.org/library/papers/42277390 | PubMed |
| 42,203,843 | Polygenic scores for risk of pancreatic ductal adenocarcinoma: evaluation of novel and published models. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/42203843 | PubMed |
| 42,098,138 | Pancreatic cancer. | Nat Rev Dis Primers | 2026 | https://conductscience.org/library/papers/42098138 | PubMed |
| 42,022,539 | Early Cancer Detection: What's Going on and What's Next. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42022539 | PubMed |
| 42,007,212 | Catching pancreatic cancer early: Are we there yet? | J Natl Cancer Cent | 2026 | https://conductscience.org/library/papers/42007212 | PubMed |
| 41,990,298 | Increasing Use of Germline Genetic Testing in Pancreatic Ductal Adenocarcinoma and Relationship to Clinical Outcome: A Single-Institution Study. | JCO Precis Oncol | 2026 | https://conductscience.org/library/papers/41990298 | PubMed |
| 41,899,580 | Genetic Predisposition to Pancreatic Cancer: A Systematic Review of Hereditary Syndromes and Familial Aggregation. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41899580 | PubMed |
| 41,885,821 | Development and Validation of a Parsimonious Risk Stratification Model for Pancreatic Cancer. | JAMA Oncol | 2026 | https://conductscience.org/library/papers/41885821 | PubMed |
| 41,820,498 | Cryptic redundancy between PAR1b and PAR1a, two members of the PAR1 kinase family, in the survival of PAR1b-knockout mice. | Sci Rep | 2026 | https://conductscience.org/library/papers/41820498 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/29922827/cited_by